RxDoctor Payments Data

Pinky Gaba, APRN

Nurse Practitioner · Middlebury, CTNPI 1780194324

Payments from drug & device makers

$414in general payments, 2019–2025

Across 19 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$168
  • Rochester Medical Corporation$76
  • Endo Pharmaceuticals Inc.$65
  • Antares Pharma, Inc.$21
  • Merck$21
  • Mission Pharmacal Company$17
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$34984%
  • Education$6516%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$414 in reported general payments places this provider in the 75th percentile of 1,162 nurse practitioner providers in Connecticut.

See all nurse practitioner providers in Connecticut

Medicare billing

Part B allowed, 2024
$10,891
Medicare patients
64
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide110$114,498
TrulicityDulaglutide34$36,864
MyrbetriqMirabegron22$25,118
MounjaroTirzepatide19$20,437
JardianceEmpagliflozin12$15,369
GemtesaVibegron15$13,271
Tamsulosin Hcl278$5,088
Finasteride126$1,625
Alfuzosin Hcl ErAlfuzosin Hcl55$1,359
Oxybutynin Chloride ErOxybutynin Chloride37$1,009
Metformin Hcl107$521
Topiramate47$512
Solifenacin Succinate17$487
Dutasteride17$336
Bupropion XlBupropion Hcl11$327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$168$25,11822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,162 nurse practitioner providers in Connecticut.

Other nurse practitioner in Middlebury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →